United States of America (USA)

Intelligence: Insuring the growing US cannabis market

Last year Malta became the first European nation to legalise cannabis after the United Nations reclassified the drug to recognise its therapeutic uses and – with other EU countries looking to follow suit – Post spoke to the specialists striving to meet…

Intelligence: Deepfakes – the next cyber threat?

Recent technological advances and increased dependence on video-based communication have accelerated the ability for fraudsters to create realistic audio and video fakes, also known as deepfakes, using artificial intelligence learning. Post investigates…

Top 30 Asia Insurers 2021: Resilience under pressure

​​​​​​​Asia Pacific non-life insurers have proven their agility and tenacity in overcoming headwinds over the past year to deliver solid results. Christie Lee, senior director of analytics for Asia-Pacific at AM Best, discusses the region’s scorecard

Interview: Steve McGill, McGill and Partners

Having successfully launched the boutique specialist (re)insurance broker only two years ago CEO Steve McGill sets out the firm’s ambitious global growth plans, the ethos underpinning the relatively new start-up and reflects on his route through the…

EQT and Vitruvian invest in CFC

The reinvestment in CFC by private equity house Vitruvian Partners and new funds from EQT is not the starting gun for an acquisition spree, according to founder and group CEO David Walsh.

RIMS CEO Mary Roth to retire

RIMS CEO Mary Roth has announced her plans to retire following the organisation's 2022 annual conference and exhibition due to be held in San Francisco next April.

CMA launches merger inquiry into Gallagher-Willis Re deal

The Competition and Markets Authority has opened a merger inquiry into Arthur J Gallagher buying Willis Towers Watson’s treaty reinsurance business looking at whether the proposed deal will lead to a lessening of competition in the UK market.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here